Sign in
Active, not recruitingNo phase

Neuroimage-guided Dual-target Continuous Theta Burst Stimulation for Generalized Anxiety Disorder

Key facts

Who runs it
Anhui Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
60 people, planned
Started
1 Nov 2024
Ended
1 Nov 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Continuous theta-burst stimulation
  • sham continuous theta-burst stimulation
Record updated
22 August 2025

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (10)Hide the full registry criteria

Who can take part

  • the patients were diagnosed by more than 2 psychiatrists and met the diagnostic criteria of DSM-5 for anxiety
  • HAMA score ≥ 14 (HAMD score < 17)
  • Age range: 18-60 years
  • Right-handed
  • Able to cooperate with the collection of general demographic information and neuropsychological testing
  • Patients are either medication-free or maintain a consistent medication regimen during cTBS treatment.-

Who cannot take part

  • History of alcohol or drug dependence
  • Diagnosis of other neuropsychiatric disorders, such as epilepsy, autism, obsessive-compulsive disorder, or autoimmune encephalitis
  • Presence of organic brain lesions detected on MRI
  • Contraindications to MRI scanning.-

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aim of this clinical trial was to determine whether image-guided dual-target cTBS is effective for anxiety disorders. The main questions it aims to answer are:

Read full original descriptionShow less

1. Does dual-target cTBS improve patients' anxiety symptoms? 2. Does dual-target cTBS improve patients' somatization symptoms? 3. Researchers will compare cTBS real and sham stimulation to determine whether cTBS is effective in treating anxiety disorders.

Participants will:

1. Received either cTBS treatment or sham stimulation for 7 consecutive days 2. Psychological assessment and MRI scan were performed before treatment, within 2 days, 2 weeks and 1 month after treatment 3. Adverse reactions during the experiment were recorded

The 2 groups in the trial

  • active cTBS groupExisting treatment, for comparison

    Dual-target active cTBS will be performed over 7 consecutive days

    Treatment: Continuous theta-burst stimulation

  • sham cTBS groupSham treatment, for comparison

    Sham stimulation of dual-target cTBS was performed for 7 consecutive days using a sham coil

    Treatment: sham continuous theta-burst stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
22 August 2025